 | | | | A large study into rare blood clots linked with AstraZeneca's COVID-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light on the side-effects from the shot. | | | | | | Italy reported 60,029 COVID-19 related cases on Tuesday, against 24,408 the day before, the health ministry said, while the number of deaths rose to 322 from 201. | | | | | | Britain reported 41,130 new COVID-19 cases on Tuesday and 205 more deaths within 28 days of a positive test, official data showed. | | | | | | Ireland on Tuesday said it will drop most of its remaining pandemic-linked restrictions from Feb. 28 as an Omicron-fuelled wave of infections ebbs. | | | | | | GlaxoSmithKline said on Tuesday its consumer healthcare venture with Pfizer will be named Haleon, as the British drugmaker confirmed the business will be spun off in mid-2022 as planned after having rejected overtures from Unilever . | | | | | | Moderna Inc said on Tuesday it had begun a late-stage study of its vaccine for Respiratory Syncytial Virus (RSV) based on the same technology used to develop its COVID-19 shots. | | | | | | Eurofins Scientific expects revenue this year to be bolstered by some 300 million euros ($339.18 million) from its coronavirus diagnostics business, the French laboratory testing group said on Tuesday after record sales helped it beat its financial targets for last year. | | | | | | People infected with the Omicron coronavirus variant are nearly 75% less likely to develop serious illness or die than those who contract the Delta variant, real world data released on Monday by South Korea's health authorities showed. | | | | | | Humana Inc said on Tuesday it has entered an agreement with activist hedge fund Starboard Value to name two independent directors to the health insurer's board. | | | | | | Here's what you need to know about the coronavirus right now: | | | | | |
